TORONTO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Shares of Scythian Biosciences Corp. (the "Company"
or “Scythian”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl: SCCYF) is pleased to announce that it will commence
trading on the Canadian Securities Exchange (the "CSE") under the symbol "SCYB" beginning when the market opens on Wednesday August
15, 2018.
“The TSX Venture Exchange policies required that we delist from the exchange prior to completion of any
acquisitions of United States based cannabis companies. With our strategic expansion into the United States, it was determined best
to delist from the TSX Venture Exchange at this point in time. CSE listing will help us achieve our goal of expanding access to
medical cannabis in the world’s leading markets,” Scythian CEO Rob Reid said.
About Scythian Biosciences Corp.
Scythian is an international cannabis company with a focus on the world’s leading markets outside of Canada. Its
fast-tracked growth has come through a number of strategic investments and regional partnerships in cultivation, distribution and
branded products across Europe, The United States, South America and the Caribbean. These significant endeavours complement the
company’s R&D partnerships with some of the world’s leading universities. It is this comprehensive approach that is positioning
Scythian as a future global frontrunner in the medical cannabis industry.
CONTACT INFORMATION
Scythian Biosciences Corp.
Rob Reid, CEO
Phone: (212) 729-9208
Email: info@scythianbio.com
For media inquiries, please contact:
David Schull or Nic Johnson
Russo Partners
(858) 717-2310
david.schull@russopartnersllc.com
nic.johnson@russopartnersllc.com
Cautionary Statements
This press release contains certain forward-looking information and statements (“forward-looking
information”) within the meaning of applicable Canadian securities legislation, that are not based on historical fact,
including without limitation, statements containing the words "believes", "anticipates", "plans", "intends", "will", "should",
"expects", "continue", "estimate", "forecasts" and other similar expressions.
Readers are cautioned to not place undue reliance on forward-looking information. Forward-looking
information is subject to a number of risks and uncertainties that may cause actual results or events to differ materially from
those contemplated in the forward-looking information, and even if such actual results or events are realized or substantially
realized, there can be no assurance that they will have the expected consequences to, or effects on the Company.
Although the Company has attempted to identify important factors that could cause actual results or events
to differ materially from those contained in the forward-looking information, there can be other factors that cause results or
events to not be as anticipated, estimated or intended. Risk factors can also be found in the Company’s annual information form
filed on SEDAR and available at www.sedar.com.
The forward-looking information contained in this press release are expressly qualified by this cautionary
statement and are made as of the date hereof. The Company disclaims any intention and has no obligation or responsibility, except
as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or
otherwise.
